During the coronavirus disease 2019 (Covid-19) pandemic, the emergence of the BA.1, BA.2, and BA.3 sublineages of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 ...
The neutralizing activity of all serum samples was tested against the B.1.429 variant and a variant of concern that first emerged in South Africa (B.1.351, also called 20H/501Y.V2). We compared this ...
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results